相关实验视频
Updated: Jul 24, 2025

07:38
Measuring In Vitro ATPase Activity for Enzymatic Characterization
Published on: August 23, 2016
18.2K
发现了VH域的发现,这些VH域可以全osterically抑制ENPP1的ENPP1
Paige E Solomon1, Colton J Bracken1,2, Jacqueline A Carozza3
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Nature chemical biology
|July 3, 2023
概括
研究人员开发了新的生物抑制剂,向ectodomain酸酶/化-1 (ENPP1),这是一个先天免疫检查点. 这些抑制剂通过阻断ENPP1对癌症免疫治疗具有前景.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 生物技术是生物技术.
背景情况:
- 在癌症中,ectodomain 酸酶/化酶-1 (ENPP1) 过度表达,通过水解循环氨酸单酸氨酸单酸 (cGAMP) 作为先天性免疫检查点.
- 目前没有报告ENPP1的生物抑制剂,这为新的癌症疗法提供了机会,与小分子相比具有潜在优势.
研究的目的:
- 为了产生针对ENPP1.1的新生物抑制剂.
- 描述ENPP1抑制的抑制机制和结构基础.
- 将ENPP1抑制剂设计成先进的免疫治疗形式.
主要方法:
- 菌体和酵母显示技术与细胞内进化相结合,用于发现针对ENPP1.1的可变重型 (VH) 单域抗体.
- 使用冷电子显微镜来确定ENPP1抑制剂复合物的高分辨率结构.
- VH域被设计成多种特定的格式和免疫疗法.
主要成果:
- 发现了一种新型的VH单域抗体,可全抑制ENPP1对cGAMP和腺三酸盐 (ATP) 的水解.
- 一个3.2 Å分辨率的冷电子显微镜结构证实了VH抑制剂的独特的全结合模式.
- 设计的多种特异格式,包括与抗PD-L1抗体的两种特异融合,显示出强大的细胞活性.
结论:
- 新型VH单域抗体通过异质机制有效抑制ENPP1.
- 结构洞察力为理解ENPP1抑制提供了基础.
- 工程ENPP1抑制剂在癌症免疫治疗中具有显著的治疗潜力.
相关概念视频
Allosteric Regulation
58.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.3K
Enzyme Inhibition
78.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.8K
GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Pinching-off of Coated Vesicles
3.2K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
GPCR Desensitization
6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K

